Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for AI-associated musculoskeletal symptoms in breast cancer
NCT01028352Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Oct 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of duloxetine in Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS), sponsored by University of Michigan Rogel Cancer Center. Started Oct 2008; status: completed.
02
Drugs
duloxetine
03
Conditions
Aromatase Inhibitor-Associated Musculoskeletal Symptoms (AIMSS)
Beyond the preview
Go deeper on NCT01028352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01028352.